ES8300093A1 - Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6 - Google Patents

Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6

Info

Publication number
ES8300093A1
ES8300093A1 ES502132A ES502132A ES8300093A1 ES 8300093 A1 ES8300093 A1 ES 8300093A1 ES 502132 A ES502132 A ES 502132A ES 502132 A ES502132 A ES 502132A ES 8300093 A1 ES8300093 A1 ES 8300093A1
Authority
ES
Spain
Prior art keywords
different substituents
dihydropyridines
medicines
processes
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES502132A
Other languages
English (en)
Other versions
ES502132A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8300093A1 publication Critical patent/ES8300093A1/es
Publication of ES502132A0 publication Critical patent/ES502132A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,4-DIHIDROPIRIDINAS CON DISTINTOS SUSTITUYENTES EN LAS POSICIONES 2 Y 6. CONSISTE EN HACER REACCIONAR ILIDEN-BETA-CETO ESTERES DE FORMULA GENERAL (I) SE HACEN REACCIONAR CON ESTERES DE ACIDO ENAMINOCARBOXILICO DE FORMULA GENERAL (II), EN CASO DADO EN PRESENCIA DE DISOLVENTES ORGANICOS INERTES A UNA TEMPERATURA COMPRENDIDA ENTRE 50 Y 150GC, PREFERENTEMENTE A LA TEMPERATURA DE EBULLICION DEL DISOLVENTE CORRESPONDIENTE. SE OBTIENE EL COMPUESTO (III). *FORMULA*.
ES502132A 1980-05-13 1981-05-12 Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6 Granted ES502132A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803018259 DE3018259A1 (de) 1980-05-13 1980-05-13 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES8300093A1 true ES8300093A1 (es) 1982-10-01
ES502132A0 ES502132A0 (es) 1982-10-01

Family

ID=6102290

Family Applications (2)

Application Number Title Priority Date Filing Date
ES502132A Granted ES502132A0 (es) 1980-05-13 1981-05-12 Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6
ES512592A Granted ES512592A0 (es) 1980-05-13 1982-05-27 Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES512592A Granted ES512592A0 (es) 1980-05-13 1982-05-27 Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6.

Country Status (17)

Country Link
EP (1) EP0039863B1 (es)
JP (1) JPS577468A (es)
AT (1) ATE5718T1 (es)
AU (1) AU541935B2 (es)
CA (2) CA1175438A (es)
DE (2) DE3018259A1 (es)
DK (1) DK210281A (es)
ES (2) ES502132A0 (es)
FI (1) FI811437L (es)
GR (1) GR74910B (es)
HU (1) HU184434B (es)
IE (1) IE51267B1 (es)
IL (1) IL62841A (es)
NO (1) NO811424L (es)
PH (1) PH18747A (es)
PT (1) PT72964B (es)
ZA (1) ZA813141B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
JPS58208271A (ja) * 1982-04-30 1983-12-03 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
JPS6094963A (ja) * 1983-10-31 1985-05-28 Teijin Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸ジエステル誘導体及びその製造法
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
JPS625958A (ja) * 1985-07-03 1987-01-12 Suntory Ltd １，４−ジヒドロピリジン誘導体、その製造法および循環系疾患治療剤
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
US5075324A (en) * 1986-12-24 1991-12-24 Boehringer Biochemia Robin S.P.A. Aralkyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical composition containing them
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
WO1991009847A1 (fr) * 1989-12-29 1991-07-11 Kaken Pharmaceutical Co., Ltd. Derive d'ethynylphenyle, production de ce derive et medicament de traitement des maladies des organes du systeme circulatoire contenant ce derive comme ingredient actif
DE59410255D1 (de) * 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792764C3 (de) * 1967-03-20 1981-04-23 Bayer Ag, 5090 Leverkusen Coronarmittel
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
SE7910521L (sv) * 1979-12-20 1981-06-21 Haessle Ab Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma

Also Published As

Publication number Publication date
GR74910B (es) 1984-07-12
PT72964A (en) 1981-06-01
EP0039863A1 (de) 1981-11-18
EP0039863B1 (de) 1983-12-28
CA1175438A (en) 1984-10-02
ATE5718T1 (de) 1984-01-15
IL62841A0 (en) 1981-07-31
IE51267B1 (en) 1986-11-26
FI811437L (fi) 1981-11-14
CA1185182A (en) 1985-04-09
ZA813141B (en) 1982-04-28
ES8304082A1 (es) 1983-02-16
PT72964B (en) 1982-06-25
NO811424L (no) 1981-11-16
IE811061L (en) 1981-11-13
AU541935B2 (en) 1985-01-31
ES512592A0 (es) 1983-02-16
DE3018259A1 (de) 1981-11-19
DK210281A (da) 1981-11-14
HU184434B (en) 1984-08-28
AU7047381A (en) 1981-11-19
DE3161760D1 (en) 1984-02-02
PH18747A (en) 1985-09-19
ES502132A0 (es) 1982-10-01
JPS577468A (en) 1982-01-14
IL62841A (en) 1984-11-30

Similar Documents

Publication Publication Date Title
GB1500581A (en) Substituted amides and their use as fungicides
ES8300093A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas con distintos sustituyentes en las posiciones 2 y 6
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
MD422C2 (ro) Derivaţi ai azolului şi compuţi intermediari pentru producerea lor
ES8307000A1 (es) Procedimiento para preparar nuevos derivados de etenilimidazol.
GB1430926A (en) 2-amino-3,4-dihydropyridines their production and their medicinal use
ATE1904T1 (de) 2-sulfonyl-chinoxaline, verfahren zu ihrer herstellung sowie ihre verwendung als mikrobizide.
ES476632A1 (es) Procedimiento para preparar derivados de anilida con susti--tucion heterociclica.
GB1509864A (en) Pyridine-4-carboxylic acid hydrazides and pyridine-4-carboxylic acid hydrazones for combatting microorganisms and for regulating plant growth
MY105529A (en) Preparation of glutaric acid derivatives.
ES449557A1 (es) Procedimiento de preparacion de polimetilen-4, 5 pirazoles.
ES442547A1 (es) Procedimiento para la preparacion de cromenopirazoles hete- rociclicamente sustituidos.
RO81676B (ro) Procedeu de preparare a unor n-aril-n-acil-3-amino-oxazolidin-2-one cu activitate fungicida
EP0201203A3 (en) Method of treatment of plants with aniline derivatives
TH5961EX (th) สารฆ่าวัชพืชชนิดไดเฟนิล อีเธอร์
GB1488465A (en) Urea derivatives and their use as herbicides
TH2282EX (th) สารเฟนนิลซัลโฟนิล กวานิดีน ที่มีกลุ่มแทนที่ชนิดใหม่สำหรับปราบวัชพืชและสารรายทาง
ES447931A1 (es) Perfeccionamientos en los metodos relativos a la preparacion y uso de esteres malonicos
ES425006A1 (es) Un procedimiento para preparar nuevos derivados de piridi- na.
ES324890A1 (es) Procedimiento para la preparacion de nuevos derivados de acridano.
ES481621A1 (es) Procedimiento para preparar derivados de 1-hidroximetil-1-o-xoprostano de las series e,a y f.
ATE50569T1 (de) Alpha-allylierte arylalkyltriazole, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
GB1088327A (en) Novel tropone sulfonic acid derivatives and a process for their preparation
ES461242A1 (es) Procedimiento para preparar derivados de isoquinolina.
ES463161A1 (es) Procedimiento para la obtencion de derivados de acidos 1- aciloximetil-4,5-dicloro-imidazol-1-carboxilicos.